Home / Companies / Longboard Pharmaceuticals, Inc. / 23 May 2024
Longboard Pharmaceuticals, Inc.: meeting of 23 May 2024
Votes reported on Form N-PX, item by item
92 Form N-PX filers reported votes at the Longboard Pharmaceuticals, Inc. meeting of 23 May 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 33.2% of reported votes for; 91 filers withheld from or voted against at least one nominee.
322 vote records from 92 filers. 32 of the 92 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
161 vote records from 92 filers. 0 of the 92 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
161 vote records from 92 filers. 6 of the 92 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | Split or no vote | For |
| BlackRock and iShares | Split or no vote | For |
| Fidelity | Split or no vote | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | Abstain or withhold * | For |
| American Century | Abstain or withhold * | For |
| Equitable | Abstain or withhold * | For |
| Charles Schwab | Split or no vote | For |
| Nuveen and TIAA | Split or no vote | For |
| ProShares and ProFunds | Abstain or withhold * | For |
| John Hancock and Manulife | Abstain or withhold * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| J.P. Morgan | Split or no vote | For |
| Goldman Sachs | Abstain or withhold * | For |
| PGIM and Prudential | Split or no vote | For |
| Northern Trust and FlexShares | Split or no vote | For |
| SEI | Split or no vote | For |
| T. Rowe Price | Split or no vote | For |
| Lincoln Financial | Split or no vote | For |
| Voya | Split or no vote | For |
| Nationwide | Abstain or withhold * | For |
| Victory Capital | Split or no vote | For |
| Brighthouse Funds | Abstain or withhold * | For |
| Guggenheim and Rydex | Abstain or withhold * | For |
| Columbia Threadneedle | Split or no vote | For |
| BNY Mellon | Split or no vote | For |
| Principal | Abstain or withhold * | For |
| Pacific Life funds | Split or no vote | For |
| Global X | Split or no vote | For |
| Hartford Funds | Split or no vote | For |
| DWS | Abstain or withhold * | For |
| MassMutual | Split or no vote | For |
| Lord Abbett | Abstain or withhold * | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Longboard Pharmaceuticals, Inc. meeting?
92 Form N-PX filers reported votes at the meeting of 23 May 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Longboard Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Longboard Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Longboard Pharmaceuticals, Inc. with a meeting date within three days of 23 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.